ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,712.69
      -0.28%
      US Tech 100
      19,431.20
      -0.34%
      Dow Jones
      41,794.60
      -0.61%
      Brent Oil
      75.085
      -0.04%
      Bitcoin
      68,344.79
      0.78%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cytek Biosciences Inc (CTKB)

      7. Cytek Biosciences Inc (CTKB) Financials

      Cytek Biosciences Inc

      Cytek Biosciences Inc (CTKB)

      NASDAQ
      5.20
      0.09
      (1.76%)
      Closed November 05 4:00PM
      Delayed by 15 minutes
      5.20
      0.00
      (0.00%)
      After Hours: 7:37PM
      Delayed by 15 minutes

      Cytek Biosciences Inc Financial Summary

      The current CTKB market cap is 683.83M. The company's latest EPS is USD -0.0924 and P/E is -56.28.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 49.69M48M58.23M44.86M46.62M
      Operating Income -9.13M-6.42M-1.64M-10.73M-8.53M
      Net Income -4.39M-6.46M5.5M-6.17M-10.43M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 92.84M127.95M164.04M193.02M
      Operating Income 13.66M9.16M-1.8M-27.85M
      Net Income 3.22M02.58M-12.15M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 525.05M519.43M494.46M492.07M483.73M
      Total Liabilities 100.88M103.91M101.39M99.45M94.6M
      Total Equity 424.18M415.52M393.06M392.61M389.12M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 219.98M463.31M519.48M494.46M
      Total Liabilities 41.69M57.92M93.93M101.39M
      Total Equity -16.03M405.39M425.55M393.06M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)
      Operating 8k-4.23M5.28M3.96M10.16M
      Investing -166.08M-122.96M-93.89M-5.75M-3.73M
      Financing 216k-8.06M-41.81M1.61M-98k
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Operating 15.16M4.63M-12.23M5.28M
      Investing -1.55M-20.99M-55.91M-93.89M
      Financing 122.61M213.56M5.51M-41.81M

      Stats and Ratios

      Market Cap 683.83M
      Price to Earnings Ratio -56.28
      Price to Sales Ratio 3.54
      Price to Cash Ratio 4.09
      Price to Book Ratio 1.74
      Dividend Yield -

      Share Statistics

      Shares Outstanding 131.51M
      Average Volume (1 week) 479.17k
      Average Volume (1 Month) 491.13k
      52 Week Change 15.30%
      52 Week High 9.87
      52 Week Low 3.80
      Spread (Intraday) 1.46 (26.55%)

      Company Info

      Company Name Cytek Biosciences Inc
      Address 850 new burton road
      dover, delaware 19904
      Website https://www.cytekbio.com
      Industry lab analytical instruments (3826)